SINTX Technologies Provides Positive Strategic Business Update for Q3 2024
Rhea-AI Summary
SINTX Technologies (NASDAQ: SINT) reported strategic updates for Q3 2024, highlighting its shift towards the medical device industry. The company ceased its armor division operations, resulting in a $4.5 million impairment charge. Financial highlights include an 18% year-over-year revenue increase and improved liquidity with $4.8 million in cash, up from $3.3 million at end-2023. The company raised $9.4 million year-to-date through strategic offerings. SINTX implemented workforce reductions and is exploring potential mergers, acquisitions, and strategic partnerships while focusing on leveraging its silicon nitride technology in medical applications.
Positive
- 18% year-over-year revenue growth in Q3 2024
- Cash position improved to $4.8 million from $3.3 million at 2023 year-end
- Successfully raised $9.4 million through strategic offerings year-to-date
Negative
- $4.5 million impairment charge from armor division closure
- Workforce reduction implemented in Q3 2024
- Strategic restructuring costs impacting current financial performance
News Market Reaction – SINT
On the day this news was published, SINT gained 0.92%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announced today a positive update on its recent strategic initiatives and financial performance, showcasing the Company’s commitment to realigning its resources and achieving long-term growth.
In line with its ongoing evaluation of a change in strategic emphasis, SINTX continues to restructure its operations to focus on high-impact, sustainable markets in the medical device industry. This transition aims to leverage the unique properties of SINTX’s silicon nitride and other advanced materials, renowned for their durability, biocompatibility, and antimicrobial properties, to drive innovations in spinal fusion devices, orthopedic implants, and surgical tools. The Company is also actively pursuing partnerships and collaborations with healthcare institutions and industry leaders to bring novel solutions to the medical community.
Eric Olson, CEO of SINTX Technologies, commented, “We remain committed to maximizing shareholder value by channeling resources towards markets with substantial growth potential and focusing on product innovations that meet the unmet needs in healthcare.”
In the third quarter of 2024, the Company made difficult, but essential, decisions to align with its renewed focus. Notably, SINTX made the decision to cease operations of its armor division and recorded a one-time
SINTX also reported significant improvement in liquidity, closing the quarter with
During the third quarter of 2024, SINTX achieved growth in revenue, with an
Looking ahead, SINTX remains focused on further expanding its footprint in the medical device sector. The Company is currently exploring new collaborations with strategic advisory partners to evaluate potential merger candidates, acquisitions, strategic partners and sale of business divisions, which could support SINTX’s ambitions to become a leader in the medical device market.
For more information, please visit www.sintx.com
About SINTX Technologies, Inc.
SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter new markets. The Company has manufacturing and R&D facilities in Utah and Maryland. For more information on SINTX Technologies or its materials platform, visit www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as: "anticipate," "believe," "project," "estimate," "expect," "strategy,” "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding advancement of ceramic technologies and exploring new avenues for growth and innovation, and the potential to pursue growth opportunities and explore strategic opportunities.
Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulty in commercializing ceramic technologies and development of new product opportunities. A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report, except as required by law.
Business and Media Inquiries for SINTX:
SINTX Technologies
801.839.3502
IR@sintx.com
FAQ
What was SINTX Technologies' (SINT) revenue growth in Q3 2024?
How much cash does SINTX (SINT) have as of Q3 2024?
What was the impairment charge for SINTX (SINT) in Q3 2024?
How much capital did SINTX (SINT) raise in 2024 year-to-date?
